Well-being and depressive symptoms among corporate workers during the COVID-19 pandemic

Aim. The study aimed to assess the well-being of corporate employees and whether it changed from the beginning of the first wave of COVID-19 (March) to the development of the second wave of the disease (October). The essence of the study was to estimate the risk of depressive symptoms in the study population. Method. The study involved 250 corporate employees. The study was conducted using the WHO-5 questionnaire and Beck's Depression Inventory. Statistical significance was determined by the Wilcoxon test (p = 0.05). Results. In the first stage of the study, the mean well-being of the respondents was assessed at 20.2 points, indicating well-being at a moderate level. It was observed that the mean wellbeing was worse among women (18.4 points) than among men (22.0 points). In the last stage of the study, the sampling of the subjects was 11.0 points - the level of poor well-being (10.0 points in women and 12.0 points in men). The percentage of people with mild and moderate depression was found to be higher in the October stage than in the March stage. Conclusions. On the basis of the study, it can be concluded that COVID-19 and its associated restrictions harmed the mental condition of the subjects.